| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3862118 | The Journal of Urology | 2014 | 10 Pages |
Abstract
EMP3 is an important prognostic indicator for selecting patients with upper urinary tract urothelial carcinoma for more intensive therapy. EMP3 is an innovative co-targeting candidate for designing ErbB2 based cancer therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yi-Wen Wang, Wei-Ming Li, Wen-Jeng Wu, Chee-Yin Chai, Hsiao-Sheng Liu, Ming-Derg Lai, Nan-Haw Chow,